Annovis Bio Inc: Annovis Plans to Conduct a Pivotal Disease-Modifying Phase III Trial in Biomarker-Positive Early Ad Patients
Annovis Bio Inc:Annovis計劃對生物標誌物陽性的早期廣告患者進行一項關鍵的疾病改善III期試驗
Annovis Bio Inc: Annovis Plans to Conduct a Pivotal Disease-Modifying Phase III Trial in Biomarker-Positive Early Ad Patients
Annovis Bio Inc:Annovis計劃對生物標誌物陽性的早期廣告患者進行一項關鍵的疾病改善III期試驗
使用瀏覽器的分享功能,分享給你的好友吧